- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/12 - 1,3-OxazinesHydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 265/12
Total number of patents in this class: 47
10-year publication summary
|
7
|
3
|
5
|
2
|
2
|
1
|
0
|
0
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 3938 |
7 |
| Kolon Industries, Inc. | 1603 |
3 |
| Samsung Electronics Co., Ltd. | 140991 |
2 |
| AstraZeneca AB | 2937 |
2 |
| Henkel IP & Holding GmbH | 570 |
2 |
| Shengyi Technology Co., Ltd. | 261 |
2 |
| University of Tennessee Research Foundation | 752 |
2 |
| Cybrexa 3, Inc. | 5 |
2 |
| Merck Sharp & Dohme LLC | 3720 |
2 |
| Bristol-myers Squibb Company | 4845 |
1 |
| F. Hoffmann-La Roche AG | 7884 |
1 |
| Hoffmann-La Roche Inc. | 3329 |
1 |
| Boehringer Ingelheim International GmbH | 4723 |
1 |
| JSR Corporation | 2491 |
1 |
| Academia Sinica | 920 |
1 |
| Alliance for Sustainable Energy, LLC | 763 |
1 |
| F.I.S. Fabbrica Italiana Sintetici S.p.A. | 123 |
1 |
| Forest Laboratories Holdings Limited | 74 |
1 |
| Fudan University | 654 |
1 |
| Irm LLC | 178 |
1 |
| Other owners | 12 |